ANGO vs XPEV · rev $320.2M vs rev $895.7M
AngioDynamics Inc (ANGO) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US.
Latest reported ANGO revenue for 2026-05-31 was $320.2M. Net income was -$36.7M. Revenue was up 9.5% from 2025-05-31 to 2026-05-31. ANGO currently screens at market cap $378.5M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
ANGO currently screens at market cap $378.5M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the ANGO and XPEV stock pages for the full models.
Not investment advice.